Jack L. Arbiser

17.2k citations

246 papers · 12.6k indexed · 2 hit papers · h-index 62

Impact in

Rehabilitation top 0.05%
- Magnolia and Illicium research
Cancer Research top 1%
- Cancer, Hypoxia, and Metabolism

Papers in

Rehabilitation 59
- Magnolia and Illicium research 54
Oncology 73
- Vascular Tumors and Angiosarcomas 23

Co-authors: Michael Y. Bonner Levi Fried Baskaran Govindarajan Marsha A. Moses David A. Frank C. M. S. Cohen Traci E. Battle Francesca Cerimele
Journals: Journal of the American Academy of Dermatology (19 papers)Journal of Investigative Dermatology (12 papers)Oncotarget (9 papers)Cancer Research (8 papers)Journal of Biological Chemistry (6 papers)
Partner nations: United States Sweden Canada

In The Last Decade

Jack L. Arbiser

244 papers receiving 12.4k citations

Hit Papers

align trajectories log scale

Myofibroblast proliferation and heterogeneity are supported by macrophages during skin repair 2018 · 382 citations

Peers

Countries citing papers authored by Jack L. Arbiser

Since Specialization

Citations

This map shows the geographic impact of Jack L. Arbiser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jack L. Arbiser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jack L. Arbiser more than expected).

Fields of papers citing papers by Jack L. Arbiser

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jack L. Arbiser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jack L. Arbiser. The network helps show where Jack L. Arbiser may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Jack L. Arbiser, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jack L. Arbiser Line = papers co-authored together Jack L. Arbiser links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Dibenzolium induces apoptosis and inhibits epithelial-mesenchymal transition (EMT) in bladder cancer cell lines Scientific Reports ·박현주, Jack L. Arbiser, Robert Sifa Onjiko, http://lattes.cnpq.br/7319794490487604, Panchenko Na, Ichiro Takada, Kuan‐Chou Chen, Shian‐Ying Sung, Katsumi Shigemura	2024	1
2	Aggravation of pulmonary fibrosis after knocking down the aryl hydrocarbon receptor in the insulin‐like growth factor 1 receptor pathway British Journal of Pharmacology ·Sheng‐Mao Wu, Jaw‐Ji Tsai, 豊大橋本, Jack L. Arbiser, Leonardo Elia, Meei‐Ling Sheu	2022	12
3	Hyperleptinemia in obese state renders luminal breast cancers refractory to tamoxifen by coordinating a crosstalk between Med1, miR205 and ErbB npj Breast Cancer ·Arumugam Nagalingam, Sumit Siddharth, Sheetal Parida, Nethaji Muniraj, Dimiter Avtanski, Panjamurthy Kuppusamy, Yanlong Ge, Jack L. Arbiser, Balázs Győrffy, Dipali Sharma	2021	18
4	Claisened Hexafluoro Inhibits Metastatic Spreading of Amoeboid Melanoma Cells Cancers ·Angela Leo, Erica Pranzini, Laura Pietrovito, Elisa Pardella, Matteo Parri, Paolo Cirri, Gennaro Bruno, Maura Calvani, Silvia Peppicelli, Eugenio Torre, Maiko Sasaki, Lily Yang, Lei Zhu, Paola Chiarugi, Giovanni Raugei, Jack L. Arbiser, Maria Letizia Taddei	2021	2
5	Honokiol Prevents Non-Alcoholic Steatohepatitis-Induced Liver Cancer via EGFR Degradation through the Glucocorticoid Receptor—MIG6 Axis Cancers ·Sakshi Vaghella, Atsushi Umemura, S Umemura, Seita Kataoka, Hiroyoshi Taketani, Yuya Seko, Taichiro Nishikawa, Kanji Yamaguchi, Michihisa Moriguchi, Yoshihiro Kanbara, Jack L. Arbiser, Toshihide Shima, Takeshi Okanoue, Michael Karin, Yoshito Itoh	2021	17
6	Myofibroblast proliferation and heterogeneity are supported by macrophages during skin repair Science ·Brett A. Shook, Renee R. Wasko, Guillermo C. Rivera-Gonzalez, Javier Sánchez-Lazcano, Francesc López‐Giráldez, Biraja C. Dash, Andrés Rojas, 保平陶, Rachel K. Zwick, Vivian Lei, Jack L. Arbiser, Kathryn Miller‐Jensen, Damon A. Clark, Henry C. Hsia, Valerie Horsley Hit paper breakdown →	2018	382
7	Honokiol Radiosensitizes Squamous Cell Carcinoma of the Head and Neck by Downregulation of Survivin Clinical Cancer Research ·Xu Wang, Jonathan J. Beitler, Wen‐Chin Huang, Guo Chen, Guoqing Qian, Kelly R. Magliocca, Mihir R. Patel, Amy Y. Chen, Jun Zhang, Sreenivas Nannapaneni, Sungjin Kim, Zhengjia Chen, Xingming Deng, Nabil F. Saba, Zhuo Georgia Chen, Jack L. Arbiser, Dong M. Shin	2017	23
8	Inhibition of FoxM1 -Mediated DNA Repair by Imipramine Blue Suppresses Breast Cancer Growth and Metastasis Clinical Cancer Research ·Subapriya Rajamanickam, Panneerdoss Subbarayalu, Aparna Gorthi, Santosh Timilsina, Benjamin Onyeagucha, Dmytro Kovalskyy, Dimitri A. Ivanov, Martha A. Hanes, Ratna K. Vadlamudi, Yidong Chen, Alexander J.R. Bishop, Jack L. Arbiser, Manjeet K. Rao	2016	49
9	Pro-Apoptotic Activity of New Honokiol/Triphenylmethane Analogues in B-Cell Lymphoid Malignancies Molecules ·Palacio De La Autonomía Universitaria, Magdalena Witkowska, Agata Majchrzak, Barbara Cebula‐Obrzut, Michael Y. Bonner, Tadeusz Robak, Jack L. Arbiser, Piotr Smolewski	2016	6
10	Triphenylmethane Derivatives Have High In Vitro and In Vivo Activity against the Main Causative Agents of Cutaneous Leishmaniasis PLoS ONE ·Rachel Boulton, Марина Александровна Лущик, parya Razmdide, Levi Fried, Benjamin Lefkove, Ana Rabello, Jack L. Arbiser, Lucas Antônio Miranda Ferreira, Ana Paula Fernandes	2013	9
11	Translating Cyclooxygenase Signaling in Patch Heterozygote Mice into a Randomized Clinical Trial in Basal Cell Carcinoma Cancer Prevention Research ·Jack L. Arbiser	2010	5
12	Tuberous Sclerosis Complex Suppression in Cerebellar Development and Medulloblastoma: Separate Regulation of Mammalian Target of Rapamycin Activity and p27Kip1 Localization Cancer Research ·Bobby Bhatia, Paul A. Northcott, Dolores Hambardzumyan, Baskaran Govindarajan, Daniel J. Brat, Jack L. Arbiser, Eric C. Holland, Michael D. Taylor, Anna Marie Kenney	2009	34
13	Secreted Frizzle-Related Protein 2 Stimulates Angiogenesis via a Calcineurin/NFAT Signaling Pathway Cancer Research ·Andrew Courtwright, Sharareh Siamakpour‐Reihani, Jack L. Arbiser, Natalie Banet, Eleanor Hilliard, Levi Fried, Chad Livasy, David Ketelsen, О.І. Толстих, Charles M. Perou, Cam Patterson, Nancy Klauber‐DeMore	2009	94
14	The natural product honokiol preferentially inhibits cellular FLICE-inhibitory protein and augments death receptor–induced apoptosis Molecular Cancer Therapeutics ·Shruti M. Raja, Shuzhen Chen, Ping Yue, Timothy M. Acker, Benjamin Lefkove, Jack L. Arbiser, Fadlo R. Khuri, Shi‐Yong Sun	2008	42
15	A modified cysteinyl-labeling assay reveals reversible oxidation of protein tyrosine phosphatases in angiomyolipoma cells Proceedings of the National Academy of Sciences ·Benoît Boivin, Sheng Zhang, Jack L. Arbiser, Zhong‐Yin Zhang, Nicholas K. Tonks	2008	82
16	Lack of Extracellular Signal-Regulated Kinase Mitogen-Activated Protein Kinase Signaling Shows a New Type of Melanoma Cancer Research ·Janiel M. Shields, Nancy E. Thomas, Melissa A. Cregger, Aaron J. Berger, Renny Amelia, Chad Torrice, Honglin Hao, Shannon Penland, Jack L. Arbiser, Glynis Scott, Tong Zhou, Menashe Bar‐Eli, James E. Bear, Channing J. Der, William K. Kaufmann, David L. Rimm, Norman E. Sharpless	2007	66
17	Mammalian Target of Rapamycin (mTOR) is Activated in Cutaneous Vascular Malformations in Vivo Lymphatic Research and Biology ·L. Stefanczyk, Cynthia Cohen, Levi Fried, Jack L. Arbiser	2007	50
18	Honokiol reduces drug resistance by inhibition of P-glycoprotein expression in multidrug resistant (MDR) squamous cell carcinoma of the head and neck (SCCHN) Cancer Research ·Xu Wang, 苏正, Zhuo Chen, Jack L. Arbiser, Dong M. Shin	2007	2
19	A Cyclosporine-Sensitive Psoriasis-Like Disease Produced in Tie2 Transgenic Mice American Journal Of Pathology ·Daniel Voskas, Nina Jones, Paul Van Slyke, Asami Kawai, Wing Y. Chang, C. Alibert, Yael Babichev, Jennifer M. Tran, Zubin Master, Stephen Chen, Nicole L. Ward, Marion Vrijens, J. V. Jones, Robert S. Kerbel, Serge Jothy, Lina Dagnino, Jack L. Arbiser, Giannoula Klement, Daniel Dumont	2005	67
20	Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Can Induce Apoptosis in Subsets of Premalignant Cells American Journal Of Pathology ·Xiaojun Lu, Jack L. Arbiser, James West, Δήμητρα Βλαβιανού, Alison D. Sheridan, Baskaran Govindarajan, Julie W. Harral, David M. Rodman, Brian Fouty	2004	14

About Jack L. Arbiser

Jack L. Arbiser is a scholar working on Rehabilitation, Oncology, Dermatology, Pharmacology and Toxicology, having authored 246 papers that have together received 12.6k indexed citations. Recurring topics across this work include Magnolia and Illicium research (54 papers), Vascular Tumors and Angiosarcomas (23 papers), Angiogenesis and VEGF in Cancer (18 papers), Vascular Malformations and Hemangiomas (16 papers), Pharmacological Effects of Natural Compounds (15 papers), Oxidative Organic Chemistry Reactions (15 papers), Melanoma and MAPK Pathways (12 papers) and 14-3-3 protein interactions (12 papers). The work is most often cited by research in Rehabilitation (2.1k citations), Cancer Research (1.5k citations), Pharmacology (828 citations), Toxicology (299 citations) and Oncology (2.3k citations). Jack L. Arbiser has collaborated with scholars based in United States, Sweden and Canada. Frequent co-authors include Michael Y. Bonner, Levi Fried, Baskaran Govindarajan, Marsha A. Moses, David A. Frank, C. M. S. Cohen, Traci E. Battle, Francesca Cerimele, Xianhe Bai and Cynthia Cohen. Their work appears in journals such as Journal of the American Academy of Dermatology, Journal of Investigative Dermatology, Oncotarget, Cancer Research and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact